Demystification and feasibility of CRISPR technology and gene editing in African laboratories.


Journal

Biology open
ISSN: 2046-6390
Titre abrégé: Biol Open
Pays: England
ID NLM: 101578018

Informations de publication

Date de publication:
15 10 2023
Historique:
medline: 23 10 2023
pubmed: 19 10 2023
entrez: 19 10 2023
Statut: ppublish

Résumé

Clustered regularly interspaced short palindromic repeats, or CRISPR, is a powerful molecular biology tool that is enabling high-quality genetic research and engineering. However, for practical reasons, but more specifically because of the lack of training and the rapid development of gene-editing technology, the technique is still not well established in African laboratories. For this reason, a consortium formed by the Institut Pasteur of Tunis and Learn and Win decided to organise an international conference and workshop on CRISPR technology in particular and gene editing in general, focusing on the low-budget model more appropriate to the African context. From 12 to 17 June 2023, more than 200 interdisciplinary researchers and students from the life sciences and more than 20 international speakers and trainers gathered at the Institut Pasteur in Tunis, Tunisia, for the First African Conference and Workshop on CRISPR to discuss the latest gene editing technologies and discoveries. This Meeting Review describes the scientific event and highlights the main outcomes of both the conferences and the practical sessions. The symposium was a real success and thrives to educate, train and network international and young scientists in the field of gene editing and gene engineering.

Identifiants

pubmed: 37855383
pii: 333683
doi: 10.1242/bio.060122
pmc: PMC10602005
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interests The authors declare no competing or financial interests.

Références

Urol Clin North Am. 1977 Jun;4(2):285-95
pubmed: 331618
Neuromuscul Disord. 2023 Aug;33(8):627-635
pubmed: 37455204
JBRA Assist Reprod. 2019 Aug 22;23(3):197-199
pubmed: 31436399
Biomaterials. 2022 Dec;291:121876
pubmed: 36334354
Mol Biotechnol. 2023 Nov;65(11):1729-1736
pubmed: 36881252
Science. 2012 Aug 17;337(6096):816-21
pubmed: 22745249
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548

Auteurs

Mohamed Jemaà (M)

Human Genetics Laboratory, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis 1006, Tunisia.
Department of Biology, Faculty of Science of Tunis, Tunis El Manar University, Tunis 2092, Tunisia.
Young Tunisian Researchers in Biology (YTRB) Network, Sfax 3000, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH